Table 2.
The survival rate and neurologic deficit scores (NDS) after ROSC.
| Group | 12 h | 24 h | 48 h | 72 h | ||||
|---|---|---|---|---|---|---|---|---|
| Survival rate | NDS | Survival rate | NDS | Survival rate | NDS | Survival rate | NDS | |
| Sham | 6/6 (100%) | 80.00 ± 0 (n = 6) | 6/6 (100%) | 80.00 ± 0 (n = 6) | 6/6 (100%) | 80.00 ± 0 (n = 6) | 6/6 (100%) | 80.00 ± 0 (n = 6) |
| CA | 10/13 (76.9%) | 47.94 ± 5.83∗ (n = 10) | 6/13 (46.2%)∗ | 53.26 ± 2.96∗ (n = 6) | 4/13 (30.8%)∗ | 58.62 ± 3.33∗ (n = 4) | 3/13 (23.1%)∗ | 73.55 ± 2.15 (n = 3) |
| PD | 13/13 (100%)# | 62.77 ± 357∗# (n = 13) | 10/13 (76.9%)# | 67.71 ± 3.23∗# (n = 10) | 8/13 (61.5%)∗# | 72.46 ± 2.44∗# (n = 8) | 5/13 (38.5%)∗ | 75.25 ± 1.68 (n = 5) |
∗ P < 0.05 versus sham group; # P < 0.05 versus CA group (n = 6).